Related content

The use of aromatase inhibitors in adjuvant therapy for early breast cancer

By Jonat Walter   Hilpert Felix   Maass Nicolai  

Cancer Chemotherapy and Pharmacology, Vol. 56, Iss. 1, 2005-11 ,pp. : 32-38

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Evaluation of the Use of Exemestane as Further Hormonal Therapy after Nonsteroidal Aromatase Inhibitors in Postmenopausal Metastatic Breast Cancer Patients

By Carlini Paolo   Michelotti Andrea   Ferretti Gianluigi   Ricci Sergio   Giannarelli Diana   Pellegrini Manuela   Cresti Nicola   Cosimo Serena Di   Bria Emilio   Papaldo Paola   Fabi Alessandra   Ruggeri Enzo Maria   Milella Michele   Alimonti Andrea   Salesi Nello   Cognetti Francesco  

Cancer Investigation, Vol. 25, Iss. 2, 2007-03 ,pp. : 102-105

Informa Healthcare

Access to resources Recommend Favorite

Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer

By Dent Susan  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 295-310

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients

By Eggemann Holm  

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 465-470

Springer Publishing Company

Access to resources Recommend Favorite

Phase III randomized adjuvant study of tamoxifen alone versus sequential tamoxifen and anastrozole in Japanese postmenopausal women with hormone-responsive breast cancer: N-SAS BC03 study

By Aihara Tomohiko  

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 379-387

Springer Publishing Company

Access to resources Recommend Favorite